Submitted by Anonymous (not verified) on 5 August 2024 - 16:30
Guideline on good pharmacovigilance practices (GVP) Module XVI – Risk minimisation measures (Rev 3)
Source:
Guideline on good pharmacovigilance practices (GVP) Module XVI – Risk minimisation measures (Rev 3)